Results 101 to 110 of about 2,541 (178)

Affordability Analysis of Selected Medicines in Iran: A National Cross-sectional Survey Using World Health Organization Out-of-Pocket Methodology. [PDF]

Iran J Pharm Res
Soleymani F, Abdi A, Mirzaei A, Raeis Zadeh MM, Zeinalkhani A, Fatemi B.   +5 more
europepmc   +1 more source

Competencies for health technology assessment professionals: a scoping review and content analysis. [PDF]

Int J Technol Assess Health Care
van Mun L, Kievit W, Oortwijn W.
europepmc   +1 more source

Interpreting patient-reported outcomes after ischemic stroke: defining minimal important difference in EQ-5D across recovery phases. [PDF]

Health Qual Life Outcomes
Li P, Zhao M, Huang Y, Sun W, Wang L, Jin X, Xie F, Li H.   +7 more
europepmc   +1 more source

Editorial - Pharmacoeconomics & Health Economics: Opening Access to Science and Practice

, 2009
S. Simoens
semanticscholar   +1 more source

Practical Considerations for Incorporating Equity More Explicitly in Australian Health Technology Assessment Processes. [PDF]

Pharmacoeconomics
Killedar A, Howell M, Howard K, Norris S.   +3 more
europepmc   +1 more source

Dynamic effects of China's national volume-based procurement on generic drug consistency evaluation: An interrupted time series analysis. [PDF]

PLoS One
Ge X, Liu X, Tian W, Peng J, Zhao M, Fang Y.   +5 more
europepmc   +1 more source

Integrating Equity in Topic Selection for Orphan Medicinal Products: Policy Implications for Health Technology Assessment in Rare Diseases. [PDF]

Appl Health Econ Health Policy
Hosseini F, Mobinizadeh M, Padula WV.
europepmc   +1 more source

Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network. [PDF]

Clin Pharmacol Ther
Jayachandran P, Ladumor MK, Vlasakakis G, Riselli A, Ilic KV, van Wijk RC, Elmeliegy M, Mukker JK, Sawant-Basak A, Long T, Dong J, Rayad N, Zhang T, DRO Network.   +13 more
europepmc   +1 more source

Antidiabetic drug utilization pattern, affordability and cost analysis in Iran from 2009 to 2021: A need to revise guideline. [PDF]

PLoS One
Zartab S, Abbasian H.
europepmc   +1 more source

Creating A Multi-Criteria Decision Analysis Tool to Enhance Value-Based Purchasing of Generic and Biosimilar Medications in Saudi Arabia: A Pilot Study. [PDF]

Clinicoecon Outcomes Res
Alruthia Y, Alhajri H, Almohammed OA, Balkhi B, Alsaqa'aby MF, Almuqbil MA, Al-Abdulkarim HA, Almutairi AR.   +7 more
europepmc   +1 more source